Immunoglobulin localization in benign and malignant lesions of the human mammary gland
- 1 July 1981
Abstract
Using direct immunofluorescence, lesions from 266 human breast specimens were studied for the presence of IgA, IgM, or IgG localization. The lesions included benign elements from 66 subcutaneous mastectomy specimens in which the absence of simultaneous breast malignancy was documented, primary breast carcinomas from 153 mastectomy specimens, and 47 biopsies containing metastatic breast cancer. A statistically significant association of IgA and IgM with benign lesions was contrasted to the association of IgG with malignant lesions. In both primary and metastatic lesions, IgG localization was associated with estrogen-receptor-poor primary cancers as compared with estrogen-receptor-rich primary cancers. Among primary breast cancer patients, IgG localization in the tumor correlated with relative lymphopenia. A shorter disease-free interval was noted in association with IgG localization among the metastatic breast lesions. No statistically significant association between stage of disease and immunoglobulin presence was demonstrable. Moderate-to-severe intraductal epithelial hyperplasias were more often associated with immunoglobulin G localization than were other benign lesions.This publication has 19 references indexed in Scilit:
- Cystosarcoma Phylloides A Steroid Receptor and Ultrastructure AnalysisAnnals of Surgery, 1979
- Breast Milk ImmunologyAmerican Journal of Diseases of Children, 1979
- Hormonal induction of the secretory immune system in the mammary gland.Proceedings of the National Academy of Sciences, 1978
- Immunology and immunotherapy of human breast cancerCancer Immunology, Immunotherapy, 1977
- Immune Complexes in Human Melanoma: A Consequence of Deranged Immune RegulationScandinavian Journal of Immunology, 1976
- Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomasInternational Journal of Cancer, 1975
- PRESENCE AND POSSIBLE ROLE OF ANTI-IgG ANTIBODIES IN HUMAN MALIGNANCYThe Lancet, 1974
- The Immune SystemScientific American, 1973
- Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant MelanomaNature, 1971
- The genetic control of immunoglobulin synthesisProceedings of the Royal Society of London. B. Biological Sciences, 1966